Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mats Johnson

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
CNS Drugs|May 24, 2018
Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity DisorderTobias Banaschewski, Mats Johnson, Peter Nagy, et al.
Attention Deficit and Hyperactivity Disorders|July 4, 2012
Fatty acids in ADHD: plasma profiles in a placebo-controlled study of Omega 3/6 fatty acids in children and adolescentsMats Johnson, Jan-Eric Månsson, Sven Ostlund, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|February 4, 2005
Computerized training of working memory in children with ADHD--a randomized, controlled trialTorkel Klingberg, Elisabeth Fernell, Pernille J Olesen, et al.
BMC Psychiatry|October 2, 2025
Thorough clinical child psychiatric diagnostic evaluation and validation of the Autism- Tics, ADHD and other comorbidities inventory (A-TAC) in a population-based sample of 9-year-oldsLinda Halldner, Sophia Eberhard, Paul Lichtenstein, et al.
Experimental Brain Research|April 13, 2023
A novel tablet-based motor coordination test performs on par with the Beery VMI subtest and offers superior temporal metrics: findings from children with pediatric acute-onset neuropsychiatric syndromeMax Thorsson, Martyna A Galazka, Parisa Hajjari, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 3, 2014
Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trialAmaia Hervas, Michael Huss, Mats Johnson, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 22, 2013
European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorderDavid Coghill, Tobias Banaschewski, Michel Lecendreux, et al.
CNS Drugs|June 27, 2013
A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescentsCésar Soutullo, Tobias Banaschewski, Michel Lecendreux, et al.
Lakartidningen|March 11, 2015
[In with updated medical knowledge when ADHD is managed]Magnus Landgren, Elisabeth Fernell, Svenny Kopp, et al.
Lakartidningen|March 9, 2023
[Survival and prematurity-related neonatal diagnoses among children born before 24 gestational weeks in Sweden 2007-2018]Eva Morsing, Pia Lundgren, Anna-Lena Hård, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
CNS Drugs|May 24, 2018
Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity DisorderTobias Banaschewski, Mats Johnson, Peter Nagy, et al.
Attention Deficit and Hyperactivity Disorders|July 4, 2012
Fatty acids in ADHD: plasma profiles in a placebo-controlled study of Omega 3/6 fatty acids in children and adolescentsMats Johnson, Jan-Eric Månsson, Sven Ostlund, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|February 4, 2005
Computerized training of working memory in children with ADHD--a randomized, controlled trialTorkel Klingberg, Elisabeth Fernell, Pernille J Olesen, et al.
BMC Psychiatry|October 2, 2025
Thorough clinical child psychiatric diagnostic evaluation and validation of the Autism- Tics, ADHD and other comorbidities inventory (A-TAC) in a population-based sample of 9-year-oldsLinda Halldner, Sophia Eberhard, Paul Lichtenstein, et al.
Experimental Brain Research|April 13, 2023
A novel tablet-based motor coordination test performs on par with the Beery VMI subtest and offers superior temporal metrics: findings from children with pediatric acute-onset neuropsychiatric syndromeMax Thorsson, Martyna A Galazka, Parisa Hajjari, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 3, 2014
Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trialAmaia Hervas, Michael Huss, Mats Johnson, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 22, 2013
European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorderDavid Coghill, Tobias Banaschewski, Michel Lecendreux, et al.
CNS Drugs|June 27, 2013
A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescentsCésar Soutullo, Tobias Banaschewski, Michel Lecendreux, et al.
Lakartidningen|March 11, 2015
[In with updated medical knowledge when ADHD is managed]Magnus Landgren, Elisabeth Fernell, Svenny Kopp, et al.
Lakartidningen|March 9, 2023
[Survival and prematurity-related neonatal diagnoses among children born before 24 gestational weeks in Sweden 2007-2018]Eva Morsing, Pia Lundgren, Anna-Lena Hård, et al.
Pageof 6